Anaphylaxis News and Research

RSS
Anaphylaxis is an acute multi-system severe type I hypersensitivity reaction. Due in part to the variety of definitions, between 1% and 15% of the population of the United States can be considered "at risk" for having an anaphylactic reaction if they are exposed to one or more allergens. Of those people who actually experience anaphylaxis, up to 1% may die as a result.
FDA grants approval for first generic version of epinephrine auto-injector

FDA grants approval for first generic version of epinephrine auto-injector

Saving sight of millions by making eye injections safe and comfortable

Saving sight of millions by making eye injections safe and comfortable

Study finds tick bite meat allergy as most common cause of anaphylaxis

Study finds tick bite meat allergy as most common cause of anaphylaxis

CNDA approves KEYTRUDA for treatment of advanced melanoma

CNDA approves KEYTRUDA for treatment of advanced melanoma

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Phase 3 study of KEYTRUDA monotherapy meets primary endpoint

Infants have less severe food-induced anaphylaxis unlike older children

Infants have less severe food-induced anaphylaxis unlike older children

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Merck announces FDA acceptance of supplemental Biologics License Application for KEYTRUDA

Most adults with allergies do not use prescribed epinephrine even in emergency situations

Most adults with allergies do not use prescribed epinephrine even in emergency situations

Men's Health Week

Men's Health Week

FDA approves first Neulasta biosimilar to help decrease infection risk during cancer treatment

FDA approves first Neulasta biosimilar to help decrease infection risk during cancer treatment

FDA approves novel enzyme therapy for adults with rare and serious genetic disease

FDA approves novel enzyme therapy for adults with rare and serious genetic disease

Scientists reveal active role of IgG antibodies in severity of anaphylaxis

Scientists reveal active role of IgG antibodies in severity of anaphylaxis

Acid-suppressing medicines and antibiotics in infancy linked to later allergic disease risk

Acid-suppressing medicines and antibiotics in infancy linked to later allergic disease risk

New study identifies possible target for treatment of dangerous allergic reactions

New study identifies possible target for treatment of dangerous allergic reactions

Duke researchers show how to retrain immune system of peanut-allergy mice

Duke researchers show how to retrain immune system of peanut-allergy mice

Trial shows safety, feasibility of adding immunotherapy during chemoradiation for head and neck cancer

Trial shows safety, feasibility of adding immunotherapy during chemoradiation for head and neck cancer

Special precautions not required when people with egg allergy take flu shots

Special precautions not required when people with egg allergy take flu shots

Many food-induced anaphylaxis cases in children occur under adult supervision

Many food-induced anaphylaxis cases in children occur under adult supervision

First short-acting ‘follow-on’ insulin receives FDA approval to treat diabetes

First short-acting ‘follow-on’ insulin receives FDA approval to treat diabetes

FDA grants approval to first biosimilar for treatment of patients with breast, stomach cancers

FDA grants approval to first biosimilar for treatment of patients with breast, stomach cancers